Plasma Levels of IL-23 and IL-17 before and after Antidepressant Treatment in Patients with Major Depressive Disorder

다국어 초록 (Multilingual Abstract)

Objective Cytokines are believed to have a role in the pathophysiology of major depression. The alteration in levels of pro-inflammatory cytokines [interleukin 1β (IL-1β), IL-2, IL-6, IL-12, interferon γ, and tumor necrosis factor α] in major depression supports the cytokine hypothesis of this illness. IL-23 and IL-17 are also pro-inflammatory cytokines, but few studies have focused on their role in major depression. This study investigated the potential role of the IL-23 and IL-17 axis in major depression.
Methods Plasma IL-23 and IL-17 levels were measured in 26 major depressive disorder (MDD) patients before and after 6-week treatment with antidepressants; these levels were measured in 28 age- and sex-matched normal controls. Depression severity was assessed using the Hamilton Depression Rating Scale (HDRS). IL-23 and IL-17 plasma levels were estimated using quantitative enzyme-linked immunosorbent assay.
Results Pre-treatment plasma levels of IL-23 and IL-17 in MDD patients were not significantly different from those of normal controls. In MDD patients, IL-23 and IL-17 levels after 6 weeks of antidepressant treatment were not different from the baseline levels. There was no significant correlation between changes in the cytokine levels and changes in the HDRS scores representing the severity of depression.
Conclusion The present study does not support a potential involvement of IL-23 and IL-17 axis in major depression. Replication and extension using a larger sample are required.

참고문헌 (Reference)

1 Munoz-Fernandez MA, "The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system" 56 : 307-340, 1998

2 Liu Y, "The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis" 15 : 183-187, 2012

3 Dubas-Slemp H, "The role of cytokines in depression" 37 : 787-798, 2003

4 Lee KM, "The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder" 6 : 1298-1304, 2006

5 Hannestad J, "The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a metaanalysis" 36 : 2452-2459, 2011

6 Maeda S, "The Th17/IL-23 Axis and Natural Immunity in Psoriatic Arthritis" 2012 : 539683-, 2012

7 Vojdani A, "The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part I" 2011 : 927294-, 2011

8 Myint AM, "Th1, Th2, and Th3 cytokine alterations in major depression" 88 : 167-173, 2005

9 Shen W, "Synergy of IL-23 and Th17 cytokines: new light on inflammatory bowel disease" 35 : 940-946, 2010

10 Schramm TM, "Sertraline treatment of interferon-alfa-induced depressive disorder" 173 : 359-361, 2000

11 Feher J, "Role of gastrointestinal inflammations in the development and treatment of depression" 152 : 1477-1485, 2011

12 Hong J, "Regulatory effects of interferon-beta on osteopontin interleukin-17 expression in multiple sclerosis" 30 : 751-757, 2010

13 Eller T, "Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder" 32 : 445-450, 2008

14 Haack M, "Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon hospital admission: effects of confounding factors and diagnosis" 33 : 407-418, 1999

15 O’Brien SM, "Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy" 41 : 326-331, 2007

16 Haastrup E, "No evidence for an anti-inflammatory effect of escitalopram intervention in healthy individuals with a family history of depression" 243 : 69-72, 2012

17 Sluzewska A, "Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine" 762 : 474-476, 1995

18 Tang C, "Interleukin-23: as a drug target for autoimmune inflammatory diseases" 135 : 112-124, 2012

19 Brambilla F, "Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia" 78 : 273-277, 2004

20 Duvallet E, "Interleukin- 23: a key cytokine in inflammatory diseases" 43 : 503-511, 2011

21 Kageyama Y, "Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis" 19 : 657-662, 2009

22 Liu Y, "IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCbeta/ Erk1/2/NF-kappaB-dependent signaling pathway" 24 : 605-612, 2012

23 Stromnes IM, "Goverman JM. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells" 14 : 337-342, 2008

24 Chen Y, "Emerging tendency towards autoimmune process in major depressive patients: A novel insight from Th17 cells" 188 : 224-230, 2011

25 American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders" American Psychiatric Press 2000

26 Irwin MR, "Depressive disorders and immunity: 20 years of progress and discovery" 21 : 374-383, 2007

27 Misery L, "Depression and psoriasis" 139 (139): S53-S57, 2012

28 Szelenyi J, "Cytokines and the central nervous system" 54 : 329-338, 2001

29 Schiepers OJ, "Cytokines and major depression" 29 : 201-217, 2005

30 Reichenberg A, "Cytokine-associated emotional and cognitive disturbances in humans" 58 : 445-452, 2001

31 Marques-Deak AH, "Cytokine profiles in women with different subtypes of major depressive disorder" 41 : 152-159, 2007

32 Seidel A, "Cytokine production and serum proteins in depression" 41 : 534-538, 1995

33 Kim YK, "Cytokine imbalance in the pathophysiology of major depressive disorder" 31 : 1044-1053, 2007

34 Carpenter LL, "Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression" 79 : 285-289, 2004

35 Kubera M, "Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio" 21 : 199-206, 2001

36 Shelton RC, "Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression" 16 : 751-762, 2011

37 Hamilton M., "A rating scale for depression" 23 : 56-62, 1960

38 Dowlati Y, "A meta-analysis of cytokines in major depression" 67 : 446-457, 2010